| 摘要 |
[Problem] To provide a therapeutic agent for cardiac tamponade, said therapeutic agent controlling the occurrence of complications accompanying cardiac tamponade by preventing or alleviating the worsening of macrocirculation and microcirculation, said worsening occurring as a result of cardiac tamponade, and by controlling local and systemic inflammation which are associated with the worsening of said types of circulation. [Solution] A pharmaceutical which contains a peptide of the present invention or a pharmaceutically acceptable salt of said peptide as an active ingredient. The pharmaceutical is useful as a therapeutic agent for cardiac tamponade (pericardial tamponade) caused by a myocardial infarction, malignant tumour metastasis, collagen disease, or the like. |
